Irumed

Lisinopril, the active ingredient in Irumed, is an ACE inhibitor presented as an oral dosage form for oral use. It is employed to lower blood pressure and to improve outcomes in heart failure and post‑myocardial infarction ventricular dysfunction in adult patients.

GNH USA supplies Irumed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lisinopril belongs to the ACE inhibitor class and is used to manage conditions linked to the renin‑angiotensin‑aldosterone system. - Hypertension: reduces elevated blood pressure and lowers cardiovascular risk. - Heart failure: improves symptoms and decreases hospitalization rates. - Post‑myocardial infarction ventricular dysfunction: helps prevent remodeling and further cardiac events.

Lisinopril may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Cough: persistent dry cough. - Dizziness or light‑headedness, especially after standing. - Headache. - Fatigue. - Mild hypotension. - Elevated blood potassium levels.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat. - Severe hypotension leading to fainting. - Acute kidney injury or worsening renal function. - Hyperkalemia with potentially dangerous cardiac effects. - Hepatic dysfunction. - Neutropenia or other blood dyscrasias.

Before initiating therapy, several safety considerations are recommended. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Renal function assessment: evaluate serum creatinine and eGFR before and during treatment. - Serum potassium: monitor especially if combined with potassium‑sparing agents. - History of angioedema: avoid use in patients with prior episodes. - Elderly patients: start at lower doses and titrate cautiously. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lisinopril can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concomitant use with aliskiren in diabetic patients. - Combination with other ACE inhibitors, ARBs, or direct renin inhibitors. - Potassium‑sparing diuretics or potassium supplements leading to hyperkalemia.

Moderate Interactions (Monitor Closely):\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs) may blunt antihypertensive effect. - Loop or thiazide diuretics: may increase risk of hypotension. - Lithium: increased lithium levels and toxicity risk. - Gold therapy: may enhance nephrotoxic potential. - Certain antibiotics (e.g., trimethoprim‑sulfamethoxazole) affecting renal function.